Greg Madison, Chief Executive Officer at Keryx Biopharma, holds 566.59K shares in Keryx Biopharma (Ticker: KERX), holds 1.89M shares in Shield Therapeutics (Ticker: GB:STX). Most recently, Greg Madison ― shares of Keryx Biopharma on ― for an estimated value of ―.